Drug-disease and drug-drug interactions : systematic examination of recommendations in 12 UK national clinical guidelines
| dc.contributor.author | Dumbreck, Siobhan | |
| dc.contributor.author | Flynn, Angela | |
| dc.contributor.author | Nairn, Moray | |
| dc.contributor.author | Wilson, Martin | |
| dc.contributor.author | Treweek, Shaun | |
| dc.contributor.author | Mercer, Stewart W | |
| dc.contributor.author | Alderson, Phil | |
| dc.contributor.author | Thompson, Alex | |
| dc.contributor.author | Payne, Katherine | |
| dc.contributor.author | Guthrie, Bruce | |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Evaluation | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.date.accessioned | 2015-05-05T10:48:01Z | |
| dc.date.available | 2015-05-05T10:48:01Z | |
| dc.date.issued | 2015-03 | |
| dc.description | Funding: The study was funded by the National Institutes for Health Services and Delivery Research Programme (NIHR HS&DR 11/2003/27). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HS&DR Programme, NIHR, NHS or the Department of Health. The funder had no role in study design, study conduct, or the decision to publish. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 8 | |
| dc.format.extent | 503878 | |
| dc.identifier | 50025514 | |
| dc.identifier | 41d6af9a-ab85-4507-aa1c-bf715ac2d6a5 | |
| dc.identifier | 25762567 | |
| dc.identifier | 84943014080 | |
| dc.identifier.citation | Dumbreck, S, Flynn, A, Nairn, M, Wilson, M, Treweek, S, Mercer, S W, Alderson, P, Thompson, A, Payne, K & Guthrie, B 2015, 'Drug-disease and drug-drug interactions : systematic examination of recommendations in 12 UK national clinical guidelines', BMJ (Clinical research ed.), vol. 350, h949. https://doi.org/10.1136/bmj.h949 | en |
| dc.identifier.doi | 10.1136/bmj.h949 | |
| dc.identifier.issn | 0959-8146 | |
| dc.identifier.other | ORCID: /0000-0002-7239-7241/work/186968485 | |
| dc.identifier.uri | http://hdl.handle.net/2164/4492 | |
| dc.identifier.vol | 350 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | BMJ (Clinical research ed.) | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | R Medicine | en |
| dc.subject | National Institute for Health Research (NIHR) | en |
| dc.subject | 11/2003/27 | en |
| dc.subject | Supplementary Data | en |
| dc.subject.lcc | R | en |
| dc.title | Drug-disease and drug-drug interactions : systematic examination of recommendations in 12 UK national clinical guidelines | en |
| dc.type | Journal article | en |
